This inhibitory role of DKK-1 in Wnt/β-catenin signaling is supported by the downregulation of DKK-1 in human colon cancers and the correlation between high DKK-1 expression and favorable responses to chemotherapy in brain tumors [3]. This evidence concerns the gene DKK1 and brain neoplasm.